BAYER: We buy in... at a maximum of EUR 43!

"Waiting for the right moment does not exist!" But supposed sell-out prices are still better than jumping up at a high level. If one leaves the topic "glyphosate" aside at the agricultural and pharmaceutical company BAYER, the omens do not seem to be so bad. And even with regard to the total herbicide, there is some hope, at least from an economic point of view, because the EU Commission wants to extend the approval by ten years; we leave the ecological question open, although it should be clear that "chemistry" is always worse for soil organisms. After difficult weeks of price decline - at the beginning of the year the share price shot up by +30% to EUR 65.66 - there is a ray of hope for the BAYER share: after an in-depth meeting with various Group managers, the US bank Citigroup also continues to conclude that the share is a "buy". The bank even leaves the price target at EUR 86, saying that although the short-term outlook is difficult, the valuation is clearly in BAYER's favor! It is clear to us that we too have not been "claiming" this since yesterday and that the cost price of EUR 56.07 is somewhat in the distance. Nevertheless, it looks very much like the new CEO Anderson is pushing ahead with the restructuring of the group. As a first step, he wants to (and will) slim down the upper and middle management, because his credo is the "Sense of Ownership" and a "Strong Mission Focus". This means that the remaining people have to concentrate on the essential tasks and they have to have the will to think and move things forward. He is an absolute opponent of time-consuming, fruitless meeting culture... so much less "babbling" and much more "delivering". Way to go! He will also abolish fixed budgets in certain areas; at previous places of activity, this had always led to increasing productivity - with stable costs. With this first "cure," is he paving the way for a major restructuring of the Group? We set a "reduction" limit at a low EUR 43!